Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
244
NMPA:244
Drug Approvals
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20253981
- Approval Date
- Apr 22, 2025
NMPA
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20253982
- Approval Date
- Apr 22, 2025
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets(I)
- Product Name
- 沙格列汀二甲双胍缓释片(Ⅰ)
- Approval Number
- 国药准字H20253883
- Approval Date
- Apr 15, 2025
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets(III)
- Product Name
- 沙格列汀二甲双胍缓释片(Ⅲ)
- Approval Number
- 国药准字H20253884
- Approval Date
- Apr 15, 2025
NMPA
Ceftazidime and Avibactam Sodium for Injection
- Product Name
- 注射用头孢他啶阿维巴坦钠
- Approval Number
- 国药准字H20253156
- Approval Date
- Jan 14, 2025
NMPA
Eldecalcitol Soft Capsules
- Product Name
- 艾地骨化醇软胶囊
- Approval Number
- 国药准字H20253039
- Approval Date
- Jan 2, 2025
NMPA
Eldecalcitol Soft Capsules
- Product Name
- 艾地骨化醇软胶囊
- Approval Number
- 国药准字H20253040
- Approval Date
- Jan 2, 2025
NMPA
Paclitaxel for Injection (Albumin Bound)
- Product Name
- 注射用紫杉醇(白蛋白结合型)
- Approval Number
- 国药准字H20249845
- Approval Date
- Dec 25, 2024
NMPA
Eribulin Mesilate Injection
- Product Name
- 甲磺酸艾立布林注射液
- Approval Number
- 国药准字H20249690
- Approval Date
- Dec 6, 2024
NMPA
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets(II)
- Product Name
- 恩曲他滨丙酚替诺福韦片(Ⅱ)
- Approval Number
- 国药准字H20249175
- Approval Date
- Oct 22, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 25
- Next
Clinical Trials
No trials found
News
No news found